146 related articles for article (PubMed ID: 35745848)
1. Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [
Nail V; Louis B; Moyon A; Chabert A; Balasse L; Fernandez S; Hache G; Garrigue P; Taïeb D; Guillet B
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745848
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4.
Junqueira MZ; Rocha NH; Sapienza MT
Radiol Bras; 2021; 54(3):171-176. PubMed ID: 34108764
[TBL] [Abstract][Full Text] [Related]
5. The value of 68 Ga-PSMA-11 positron emission tomography/computerized tomography in evaluating the lacrimal and salivary glands function.
Li JF; Qin LP; Wu QY; Guo XH; Yang JZ; Wan QC; Cheng MH; Xie LJ
Clin Rheumatol; 2022 May; 41(5):1543-1550. PubMed ID: 35089469
[TBL] [Abstract][Full Text] [Related]
6. Potential Applications of
Zhao Y; Xia Y; Liu H; Wang Z; Chen Y; Zhang W
Contrast Media Mol Imaging; 2020; 2020():1097516. PubMed ID: 32410918
[TBL] [Abstract][Full Text] [Related]
7. [
Peters SMB; Hofferber R; Privé BM; de Bakker M; Gotthardt M; Janssen M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Costa PF; Nagarajah J; Konijnenberg MW; Jentzen W
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1101-1112. PubMed ID: 34623453
[TBL] [Abstract][Full Text] [Related]
8. PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
Mohan V; Vogel WV; Valk GD; de Boer JP; Lam MGEH; de Keizer B
Mol Imaging; 2020; 19():1536012120934992. PubMed ID: 32619138
[TBL] [Abstract][Full Text] [Related]
9. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
[TBL] [Abstract][Full Text] [Related]
10. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of
Hofman MS; Eu P; Jackson P; Hong E; Binns D; Iravani A; Murphy D; Mitchell C; Siva S; Hicks RJ; Young JD; Blower PJ; Mullen GE
J Nucl Med; 2018 Apr; 59(4):625-631. PubMed ID: 28986512
[No Abstract] [Full Text] [Related]
11. Predicting the effect of different folate doses on [
Siebinga H; Hendrikx JJMA; Huitema ADR; de Wit-van der Veen BJ
EJNMMI Res; 2023 Jun; 13(1):60. PubMed ID: 37318681
[TBL] [Abstract][Full Text] [Related]
12. [
Rosar F; Schaefer-Schuler A; Bartholomä M; Maus S; Petto S; Burgard C; Privé BM; Franssen GM; Derks YHW; Nagarajah J; Khreish F; Ezziddin S
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4736-4747. PubMed ID: 35930033
[TBL] [Abstract][Full Text] [Related]
13. What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake.
Kuo HT; Lin KS; Zhang Z; Zhang C; Merkens H; Tan R; Roxin A; Uribe CF; Bénard F
Theranostics; 2022; 12(14):6179-6188. PubMed ID: 36168623
[TBL] [Abstract][Full Text] [Related]
14. Effect of External Cooling on
Yilmaz B; Nisli S; Ergul N; Gursu RU; Acikgoz O; Çermik TF
J Nucl Med; 2019 Oct; 60(10):1388-1393. PubMed ID: 30850503
[TBL] [Abstract][Full Text] [Related]
15. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
16. First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for
Rupp NJ; Umbricht CA; Pizzuto DA; Lenggenhager D; Töpfer A; Müller J; Muehlematter UJ; Ferraro DA; Messerli M; Morand GB; Huber GF; Eberli D; Schibli R; Müller C; Burger IA
J Nucl Med; 2019 Sep; 60(9):1270-1276. PubMed ID: 30737300
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry of
Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
[No Abstract] [Full Text] [Related]
18. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
[TBL] [Abstract][Full Text] [Related]
19. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
[TBL] [Abstract][Full Text] [Related]
20.
van Boxtel W; Lütje S; van Engen-van Grunsven ICH; Verhaegh GW; Schalken JA; Jonker MA; Nagarajah J; Gotthardt M; van Herpen CML
Theranostics; 2020; 10(5):2273-2283. PubMed ID: 32089741
[No Abstract] [Full Text] [Related]
[Next] [New Search]